Herpes Cure Advocacy Impact
Have you been following the transformational changes Herpes Cure Advocacy has initiated in the landscape of herpes?
We have, since organizing as the country’s only patient advocacy organization for HSV, have done the following:
- Lobbied US Congress to direct The Dept. of Health and Human Services (HHS) to develop a national strategy for herpes with $250,000 in funding for an FTE and HSV strategy development
- In 2022, National Institutes of Health (NIH) convened a 2-day workshop on herpes cure, vaccine, and treatment research
- In 2023, NIH assembled a multi-council working group and subsequently released a 5-year HSV research strategy
- In 2023, based upon clinical and laboratory data provided by HCA, the Food and Drug Administration (FDA) issued a safety communication about the poor performance of herpes simplex virus antibody tests
- In February 2024, OASH released a draft addendum to the National STI Strategy addressing herpes
- Finally, HCA prompted the CDC to undertake efforts to evaluate the burden of neonatal herpes and consider making it a nationally notifiable condition
Give Today and Join the Fight →
Every donation – whether $10 or $10,000 – moves us closer to a world where herpes is effectively treated and free from stigma.
Questions about giving? Contact us at info@herpescureadvocacy.com or 267-797-7139.
Want the latest news on herpes cure, treatment and prevention?
Sign up for our newsletter and make sure you never miss a thing.
